Janet Woodcock
American physician / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Janet Woodcock?
Summarize this article for a 10 year old
Janet Woodcock (born August 29, 1948) is an American physician serving as Principal Deputy Commissioner of Food and Drugs, having previously served as Acting Commissioner of the U.S. Food and Drug Administration (FDA).[2] She joined the FDA in 1986, and has held a number of senior leadership positions there, including terms as the Director of Center for Drug Evaluation and Research (CDER) from 1994 to 2004 and 2007 to 2021.[3]
This biographical article is written like a résumé. (January 2022) |
Janet Woodcock | |
---|---|
Principal Deputy Commissioner of Food and Drugs | |
Assumed office February 18, 2022 | |
President | Joe Biden |
Preceded by | Amy Abernethy |
Commissioner of Food and Drugs | |
Acting | |
In office January 20, 2021 – February 17, 2022 | |
President | Joe Biden |
Preceded by | Stephen Hahn |
Succeeded by | Robert Califf |
Director of the Center for Drug Evaluation and Research | |
In office October 1, 2007 – April 12, 2021 Acting: October 1, 2007 – April 1, 2008 | |
Preceded by | Steven K. Galson |
Succeeded by | Patrizia Cavazzoni |
In office May 1994 – April 2004 | |
Preceded by | Carl Peck |
Succeeded by | Steven K. Galson |
Personal details | |
Born | (1948-08-29) August 29, 1948 (age 75) Washington, Pennsylvania, U.S. |
Spouse | Roger Miller[1] |
Education | Bucknell University (BS) Northwestern University (MD) |
Awards | Biotechnology Heritage Award (2019) |
Woodcock has overseen the modernization and streamlining of CDER and FDA, introducing new initiatives to improve the timeliness and transparency of FDA procedures, and the safety, quality and effectiveness of drugs. She informs the United States Congress and other government bodies about the FDA and its concerns, helping to develop policy recommendations and legislation. In 2015, Woodcock received a Lifetime Achievement Award from the Institute for Safe Medication Practices in recognition of “a significant career history of making ongoing contributions to patient safety.”[4] She has also received the 2019 Biotechnology Heritage Award.[5]